tiprankstipranks
Trending News
More News >
SkinBioTherapeutics plc (GB:SBTX)
:SBTX
UK Market
Advertisement

SkinBioTherapeutics (SBTX) Financial Statements

Compare
18 Followers

SkinBioTherapeutics Financial Overview

SkinBioTherapeutics's market cap is currently £42.96M. The company's EPS TTM is p-0.012; its P/E ratio is ―; SkinBioTherapeutics is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Currency in GBP

SkinBioTherapeutics Earnings and Revenue History

SkinBioTherapeutics Debt to Assets

SkinBioTherapeutics Cash Flow

SkinBioTherapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis